📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
4 articles
AVG GRADE
NEUTRAL
score: 0.25
SENTIMENT
NEUTRAL
TOTAL VIEWS
7
RECENT COVERAGE · 5 ARTICLES
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
Zealand Pharma (ZEAL) has disclosed routine transactional activity under its share buy-back program for week 26 of 2026. This represents...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma disclosed insider transactions involving shares and related securities by officers and their closely associated parties....
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
Zealand Pharma has disclosed routine share repurchase activity for week 25 of 2026 as part of its ongoing capital allocation program....
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
Zealand Pharma disclosed routine share repurchase activity during week 24 of 2026 as part of an ongoing authorized buy-back program....
Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data
LLY, TEVA, GSK, and ZEAL are driving a significant biotech rally this week, anchored by multiple FDA and regulatory approvals across...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice